Akubio
www.akubio.comAkubio Limited develops and provides systems for real time analysis of biomolecular behaviour, using acoustic detection technology. Its proprietary RAP technology provides robust, cost-effective class leading sensitivity for the detection and measurement of protein and small molecule interactions.
It is privately owned, backed by a number of investors. The principal shareholding is owned by Abingworth Management Ltd, a leading UK based venture capital company specialising in unquoted Life Science companies, and named European Venture Capital Company of the Year 2004.
Other shareholdings are held by GlaxoSmithKline, Cambridge University, the Cambridge Challenge Fund, the founders, employees, and other individuals.
Staff
Contact details
Cambridge
CB4 0GJ
United Kingdom
Tel: +44(0)1223 225 335
Fax: +44(0)1223 225 336